Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Extending its foothold in the rapidly developing energy space, IntercontinentalExchange Inc. ( ICE - Analyst Report ) announced an alliance with Gasunie that offers gas infrastructure. Under this deal, both the entities jointly formed a new venture from the spot gas and derivative business of Amsterdam-based exchange – APX-ENDEX.
Accordingly, IntercontinentalExchange owns 79.12% in the derivatives and spot gas business of APX-ENDEX, while Gasunie holds a share similar to the ealier level, which is 20.88%. Prior to this business restructuring, TenneT owned 56.1% of APX-ENDEX, Gasunie held 20.9%, Elia had 20% and Fluxys owned 3%.
Although the value of the deal remains undisclosed, it will be funded by the excess cash of the company. The transaction is expected to culminate in the first quarter of 2013, subject to regulatory approvals.
Post the acquisition, APX-ENDEX will be reorganized and spun-off its business into two distinct units – one is a power spot and clearing business and the other is a derivatives and spot natural gas business.
Meanwhile, the gas business is located in Europe’s leading natural gas trading hubs –around the Title Transfer Facility (TTF) Virtual Trading Point in the Netherlands. This business will also encompass the UK On-the-day Commodity Market (OCM) and the Belgian Zeebrugge Trading Point (ZTP), which is set to launch at the end of this month.
The acquisition of APX-ENDEX and expansion of the energy portfolio in Europe is another attempt by IntercontinentalExchange to evolve through its hedging strategies, product modification and innovation, thereby supporting volumes and the top-line growth in the long run. Allying with the leading Gasunie further helps IntercontinentalExchange achieve its aim of building a highly liquid and competent hedging and trading platform in the gas and power markets of Europe.
Additionally, the company already offers more than 730 cleared OTC energy contracts, including more than 640 new cleared OTC contracts since the launch of ICE Clear Europe in November 2008.
Such products incorporate transparency and risk-management features to the trading, which should help in gaining the confidence and attracting the untapped customer-base. We believe that the latest acquisition will further enhance IntercontinentalExchange’s market retention capacity, also reflecting sound utilization of its capital.
Moreover, the outlay of its growth plan, earlier this year, by dominant players such as NYSE Euronext Inc. ( NYX - Analyst Report ) and CME Group Inc. ( CME - Analyst Report ) through acquisitions, setting up of clearinghouses along with new product and service initiations in the derivatives market, primarily focused on the expansion in Europe. Thus, IntercontinentalExchange’s latest acquisition also blends well with the ongoing competitive growth strategy.
IntercontinentalExchange carries a Zacks Rank #3, which implies a short-term Hold rating, while the long-term recommendation stands at Neutral.
Read the full reports :
Analyst Report on ICE
Analyst Report on CME
Analyst Report on NYX